Option chain shows key data for SomnoMed's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SomnoMed.

SomnoMed (OTC:SOMNF) Stock, Option Chain

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

News

Intraday Update

Markets

Movers

Trading Ideas

AIQUY

ALBY

ALIAF

ALLK

ALLVF

ALPMY

ANSS

APPS

ARES

ARVN

ASLN

BDSI

BlackRock New York Municipal Income Trust II

BLMN

BNMDF

BSRTF

CACI

CARCY

CASY

CDAY

CJRCF

CMTL

COLL

CPXWF

CSLLY

CVNA

DPUKY

DRTGF

DXCM

EBMT

EXPERT SYSTEM S P A by EXPERT SYSTEM S P A

EXSPF

Flaherty Crumrine/Claymore Preferred Securities

FISV

FLMZF

FTAI

FWONK

GAIN

GILXF

GLPG

GMRE

GOBK

HARP

HLMAF

HNGR

HXGBY

INCY

INSG

KLPEF

KPTI

KRYS

KYOCY

LARK

LITE

LOGI

LPLA

MDXG

MONRY

MTEM

MYOK

NBIX

NILA

NLTX

NMPNF

PCTY

PFGC

PLMR

PNFP

PTON

Stocks That Hit 52-Week Highs On Friday

SomnoMed Ltd

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited is calling on shareholders to participate in its upcoming Annual General Meeting...

SomnoMed Limited Invites Shareholder Participation in Key Votes

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited reported a net positive cash flow from operations of AUD 1.12 million for the qu...

SomnoMed Limited Shows Strong Cash Flow Momentum

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited reported a robust first quarter for FY25, with revenue surging by 18.2% to $25.3...

SomnoMed Limited Sees Strong Growth and FDA Milestone

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited's recent investor presentation highlights the speculative nature of its securiti...

SomnoMed Limited: Evaluating Investment Risks and Opportunities

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited has upgraded its FY25 financial guidance, expecting a 5% revenue increase to app...

SomnoMed Projects Growth and Appoints New CFO

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited has undergone significant changes with the appointment of co-CEOs Karen Borg and...

SomnoMed Limited Sees Growth and Innovation in 2024

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited's Annual General Meeting saw the approval of all proposed resolutions, including...

SomnoMed Limited Announces AGM Resolutions Approval

Somnomed Limited (AU:SOM) has released an update. Somnomed Limited has announced a significant increase in options held by its director, Michael Go...

Somnomed Limited Director Increases Options Holdings

Somnomed Limited (AU:SOM) has released an update. Somnomed Limited has announced a significant change in the shareholding of its director, Gaetano ...

Somnomed Director Increases Stake with Major Acquisition

Somnomed Limited (AU:SOM) has released an update. Somnomed Limited announced a change in the indirect interest of its director, Benjamin Gisz, who ...

Somnomed Limited: Director Acquires 300,000 Options

SOMNF

SomnoMed

Comments

SomnoMed

SomnoMed (SOMNF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga